MedPath

Negative Pressure Wound Therapy for Surgical Site Infection Prevention in Common Femoral Artery Exposure

Not Applicable
Withdrawn
Conditions
Groin Infections
Surgical Site Infection
Interventions
Device: Negative Pressure Pressure Wound Therapy
Procedure: Standard Wound Care
Registration Number
NCT03935659
Lead Sponsor
Henry Ford Health System
Brief Summary

The purpose of this randomized clinical trial is to investigate the role of negative pressure wound therapy (NPWT) vs standard sterile gauze therapy on the incidence of surgical site infections (SSI) in primarily closed groin incisions in high risk patients undergoing any open common femoral artery exposure for a vascular surgery procedure.

Detailed Description

Eligible patients are randomized pre-operatively into either a standard dressing or NPWT for the groin incision.

* 1 The control group receive a standard sterile gauge dressing over the groin incision. The dressing is removed on post-operative day #2 and the wound is inspected for a SSI or dehiscence, followed by daily dressing changes and wound inspections until discharge.

* 2 The intervention group will receive a NPWT dressing which will be applied in the operating room under sterile conditions. The NPWT dressing will be removed on Post operative day 5. The wound is inspected for a SSI or dehiscence, followed by daily dressing changes and wound inspections until discharge.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

One or more of the following

  • Body Mass Index >30 kg/m2
  • Critical limb ischemia defined by Ankle Brachial Index<0.35, rest pain, tissue loss and/or non-healing ulcers
  • Procedure time >240 min
  • End Stage Renal Disease on dialysis
  • Glycated hemoglobin ≥ 8.5%
  • Transfusion ≥ 3 units packed Red Blood Cells
  • Previous femoral artery cut-down
Exclusion Criteria

Any of the following

  • Preexisting groin infection
  • Complete vacuum seal cannot be achieved with negative pressure device
  • Allergy to Adhesive Material
  • Groin Surgery within last 30 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Negative Pressure wound therapyNegative Pressure Pressure Wound TherapyThe intervention group will receive a negative pressure dressing which will be applied in the operating room under sterile conditions. The brand of negative pressure dressing will be based on surgeon preference or center availability. The NPWT dressing will be removed on day 5 postoperatively or at discharge, whichever occurs first, and the groin wound inspected for any evidence of infection or dehiscence, and daily thereafter until discharge.
Standard gauze therapyStandard Wound CareThe control group will receive a standard sterile gauge dressing over the groin incision. The dressing will be removed on post-operative day #2 and the wound will be inspected for any complications, followed by daily dressing changes and wound inspections until discharge.
Primary Outcome Measures
NameTimeMethod
Superficial surgical site infection30 days postoperatively

Surgical site infection as defined by the Center for disease control and prevention criteria

Secondary Outcome Measures
NameTimeMethod
Mortality30 days

Occurrence of mortality within 30 days of surgery

Local reaction to negative wound dressing5 days postoperatively

Occurrence of a local reaction at the site of the negative pressure apparatus during application

Limb Loss30 days and 1 year

Occurrence of ipsilateral limb loss SSI within 30 days and 1 year of surgery

Emergency department visit for wound complicationwithin 30 days of surgery

Number of participants returning to the emergency department for wound complications within 30 days of surgery

Trial Locations

Locations (1)

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath